WORCESTER, Mass., Aug. 12, 2011 (GLOBE NEWSWIRE) -- RXi Pharmaceuticals Corporation (Nasdaq:RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using targeted biotherapeutics, announced today that the Company's President and Chief Executive Officer, Mark J. Ahn, Ph.D., will present a corporate overview at the Wedbush Securities 2011 Life Sciences Management Access Conference on Wednesday, August 17, 2011 at 12:40pm ET at the Le Parker Meridien in New York City.
